Ocugen, Inc. — Director's Dealing 2019

Feb 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2019-02-08

Reporting Person: RAKIN KEVIN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-08	Common Stock	M	173076	—	Acquired	418639	Direct
2019-02-08	Common Stock	M	33333	—	Acquired	66666	Indirect
2019-02-08	Common Stock	M	33333	—	Acquired	66666	Indirect
2019-02-08	Common Stock	M	111111	—	Acquired	257846	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	173076	Disposed	2023-10-10	Common Stock (173076)	Direct
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	33333	Disposed	2021-11-22	Common Stock (33333)	Indirect
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	33333	Disposed	2021-11-22	Common Stock (33333)	Indirect
2019-02-08	Common Stock Warrant (Right to Buy)	$0.01	M	111111	Disposed	2021-11-22	Common Stock (111111)	Indirect

Footnotes

F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019.

F2: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Sarah Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose, except to the extent of his pecuniary interest therein.

F3: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Julia Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.

F4: The reportable securities are owned by the Kevin L Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.